High affinity interactions and signal transduction between Aβ oligomers and TREM2

Rare coding variant in the Triggering receptor expressed on myeloid cells 2 (TREM2) are associated with increased risk for Alzheimer’s disease (AD), but how they confer this risk remains uncertain. We assessed binding of TREM2, AD associated TREM2 variants to various forms of Aβ and APOE in multiple assays. TREM2 interacts directly with various forms of Aβ, with highest affinity interactions observed between TREM2 and soluble Aβ42 oligomers. We confirm the previous interaction between APOE3 and APOE4 and TREM2. High affinity binding of TREM2 to Aβ oligomers is characterized by very slow dissociation. Pre-incubation with Aβ is shown to block the interaction of APOE. In cellular assays, AD-associated variants of TREM2 reduced the amount of Aβ42 internalized, and in NFAT assay the R47H variant decreased NFAT signaling activity in response to Aβ42. These studies demonstrate i) a high affinity interaction between TREM2 and Aβ oligomers that can block interaction with another ligand and ii) that AD-associated TREM2 variants bind Aβ with equivalent affinity but show loss of function in terms of signaling and Aβ internalization.

[1]  M. Colonna,et al.  Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism , 2018, The Journal of experimental medicine.

[2]  D. Holtzman,et al.  Behavioral and transcriptomic analysis of Trem2-null mice: not all knockout mice are created equal , 2017, Human molecular genetics.

[3]  C. Haass,et al.  An Alzheimer‐associated TREM2 variant occurs at the ADAM cleavage site and affects shedding and phagocytic function , 2017, EMBO molecular medicine.

[4]  P. S. St George-Hyslop,et al.  TREM2 shedding by cleavage at the H157‐S158 bond is accelerated for the Alzheimer's disease‐associated H157Y variant , 2017, EMBO molecular medicine.

[5]  Nick C Fox,et al.  Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease , 2017, Nature Genetics.

[6]  D. Kober,et al.  TREM2-Ligand Interactions in Health and Disease. , 2017, Journal of molecular biology.

[7]  David V. Hansen,et al.  TREM2, Microglia, and Neurodegenerative Diseases. , 2017, Trends in molecular medicine.

[8]  R. Tanzi,et al.  Alzheimer's disease-associated TREM2 variants exhibit either decreased or increased ligand-dependent activation , 2017, Alzheimer's & Dementia.

[9]  Adrian Danek,et al.  Early changes in CSF sTREM2 in dominantly inherited Alzheimer’s disease occur after amyloid deposition and neuronal injury , 2016, Science Translational Medicine.

[10]  Asha A. Nair,et al.  A candidate regulatory variant at the TREM gene cluster associates with decreased Alzheimer's disease risk and increased TREML1 and TREM2 brain gene expression , 2016, Alzheimer's & Dementia.

[11]  Carlos Cruchaga,et al.  Neurodegenerative disease mutations in TREM2 reveal a functional surface and distinct loss-of-function mechanisms , 2016, eLife.

[12]  J. Grutzendler,et al.  TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy , 2016, Neuron.

[13]  Lino C. Gonzalez,et al.  TREM2 Binds to Apolipoproteins, Including APOE and CLU/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia , 2016, Neuron.

[14]  D. Holtzman,et al.  TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques , 2016, The Journal of experimental medicine.

[15]  L. Tan,et al.  A rare coding variant in TREM2 increases risk for Alzheimer's disease in Han Chinese , 2016, Neurobiology of Aging.

[16]  M. Colonna,et al.  TREM2 variants: new keys to decipher Alzheimer disease pathogenesis , 2016, Nature Reviews Neuroscience.

[17]  D. Holtzman,et al.  TREM2 Function in Alzheimer's Disease and Neurodegeneration. , 2016, ACS chemical neuroscience.

[18]  D. Rujescu,et al.  The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease , 2015, Alzheimer's & Dementia.

[19]  S. Younkin,et al.  Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)* , 2015, The Journal of Biological Chemistry.

[20]  M. Farzan,et al.  The Triggering Receptor Expressed on Myeloid Cells 2 Binds Apolipoprotein E* , 2015, The Journal of Biological Chemistry.

[21]  R. Tanzi TREM2 and Risk of Alzheimer's Disease--Friend or Foe? , 2015, The New England journal of medicine.

[22]  D. Holtzman,et al.  Three dimensions of the amyloid hypothesis: time, space and 'wingmen' , 2015, Nature Neuroscience.

[23]  S. Lincoln,et al.  TREM2 is associated with increased risk for Alzheimer’s disease in African Americans , 2015, Molecular Neurodegeneration.

[24]  R. Ransohoff,et al.  TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer’s disease mouse models , 2015, The Journal of experimental medicine.

[25]  D. Holtzman,et al.  TREM2 lipid sensing sustains microglia response in an Alzheimer’s disease model , 2015, Cell.

[26]  Nathan D. Price,et al.  IL-10 Alters Immunoproteostasis in APP Mice, Increasing Plaque Burden and Worsening Cognitive Behavior , 2015, Neuron.

[27]  L. Tan,et al.  Upregulation of TREM2 Ameliorates Neuropathology and Rescues Spatial Cognitive Impairment in a Transgenic Mouse Model of Alzheimer’s Disease , 2014, Neuropsychopharmacology.

[28]  J. Molinuevo,et al.  TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis , 2014, Science Translational Medicine.

[29]  A. Goate,et al.  Coding variants in TREM2 increase risk for Alzheimer's disease. , 2014, Human molecular genetics.

[30]  D. Holtzman,et al.  Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2 , 2014, Molecular Neurodegeneration.

[31]  T. Golde,et al.  γ-Secretase Processing and Effects of γ-Secretase Inhibitors and Modulators on Long Aβ Peptides in Cells* , 2013, The Journal of Biological Chemistry.

[32]  H. Neumann,et al.  Sequential Proteolytic Processing of the Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) Protein by Ectodomain Shedding and γ-Secretase-dependent Intramembranous Cleavage* , 2013, The Journal of Biological Chemistry.

[33]  W. Streit,et al.  Alzheimer's disease risk alleles in TREM2 illuminate innate immunity in Alzheimer's disease , 2013, Alzheimer's Research & Therapy.

[34]  Matthew H. Bailey,et al.  GWAS of Cerebrospinal Fluid Tau Levels Identifies Risk Variants for Alzheimer’s Disease , 2013, Neuron.

[35]  K. Coggeshall,et al.  TREM2- and DAP12-Dependent Activation of PI3K Requires DAP10 and Is Inhibited by SHIP1 , 2010, Science Signaling.

[36]  W. Seaman,et al.  A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia , 2009, Journal of neurochemistry.

[37]  Kristina D. Micheva,et al.  Oligomeric amyloid β associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques , 2009, Proceedings of the National Academy of Sciences.

[38]  L. Peltonen,et al.  The genetic causes of basal ganglia calcification, dementia, and bone cysts , 2005, Neurology.

[39]  G. Krafft,et al.  In Vitro Characterization of Conditions for Amyloid-β Peptide Oligomerization and Fibrillogenesis* , 2003, The Journal of Biological Chemistry.

[40]  L. Peltonen,et al.  Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. , 2002, American journal of human genetics.

[41]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[42]  O. Salonen,et al.  CNS manifestations of Nasu–Hakola disease , 2001, Neurology.

[43]  R. Ransohoff,et al.  Disease progression-dependent effects of TREM2 deficiency in a mouse model of Alzheimer's disease. , 2016, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[44]  Clemens F Kaminski,et al.  Optical Super-Resolution Imaging of β-Amyloid Aggregation In Vitro and In Vivo: Method and Techniques. , 2016, Methods in molecular biology.

[45]  L. Peltonen,et al.  The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2. , 2005, Neurology.

[46]  L. Higgins,et al.  A Transgenic Mouse Model of Alzheimer’s Disease , 1994 .